Key points are not available for this paper at this time.
Answers are grounded in this paper and cite their sources.
Characterizes compensated HF hemodynamics in BIO T0-2 hamsters; supports model utility but leaves open clinical translation.
OBJECTIVE: The recently developed BIO T0-2 strain of cardiomyopathic hamster shows a uniform pathogenesis of dilated cardiomyopathy and represents a useful model of congestive heart failure. Although used in biochemical studies, BIO T0-2 animals have not been characterised by haemodynamic measurements. The aim was to compare the systemic and the regional haemodynamic variables in conscious BIO T0-2 animals at a stage of compensated heart failure with those of age matched normal hamsters of BIO F1B designation. METHODS: Hamsters were studied at 8-10 months of age, a stage at which the BIO T0-2 animals have been found to have non-oedematous heart failure. Catheters were implanted in normal and cardiomyopathic hamsters. Following a 3 h recovery, systemic and regional haemodynamic variables were measured with pressure transducers and radioactive microspheres. RESULTS: BIO T0-2 hamsters had lower (p < 0.05) mean arterial pressure [83(SEM 3) v 126(2) mm Hg] and cardiac index [205(19) v 338(25) ml.min-1.kg-1], and higher (p < 0.05) left ventricular end diastolic pressure [21(1) v 4(1) mm Hg] and total peripheral resistance index [30(4) v 15(2) mm Hg.min.ml-1.kg-1] than BIO F1B animals. Blood flows to the heart and kidneys were less (p < 0.05) in BIO T0-2 than in BIO F1B animals. CONCLUSIONS: The haemodynamic profile in the BIO T0-2 strain of cardiomyopathic hamsters is characterised by low cardiac output, increased preload, and reduced renal blood flow, and resembles that in many patients with congestive heart failure.
No takes yet. Share an insight, caveat, or question.
Panchal et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: